Is Milk Thistle Liver Enzymes Randomized Trial safe?

The current Migaku evidence database contains 1 reusable source document for Milk Thistle Liver Enzymes Randomized Trial. This answer focuses on safety, limits, and clinician-discussion contexts. - 1 2 1 3 4 5 6 Metabolic dysfunction-associated steatotic liver disease [MASLD; formerly known as non-alcoholic fatty liver disease (NAFLD)] is caused by chronic fat deposition in the liver and is the result of complex interactions involving metabolic dysregulation and insulin resistance (). [Messier Helen (2026); evidence level 2] - Some patients with MASLD will have metabolic dysfunction-associated steatohepatitis (MASH) which is characterized by hepatocellular ballooning and lobular inflammation (). [Messier Helen (2026); evidence level 2] - MASLD is associated with the development of cirrhosis, liver failure, liver cancer, and type 2 diabetes (). [Messier Helen (2026); evidence level 2] - Imaging tests, including FibroScan, which estimates the amount of fat and fibrosis present in the liver, are used to look for signs of MASLD (). [Messier Helen (2026); evidence level 2] Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording. This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.